2025
Matthew Passes His DPhil Viva
Jun 2025
Matthew concludes his doctoral studies with a successful viva defence and can finally add DPhil (Oxon) to his long list of titles! Congratulations; we look forward to seeing what the future holds for you.
Eva passes her DPhil viva
Apr 2025
Congratulations Eva for passing your DPhil viva voce! We wish you all the best for the future and hope to see you again.
Tom passes his DPhil confirmation
Apr 2025
We congratulate Tom Grimes for passing his DPhil confirmation! A few days later, he also delivered a fascinating talk at the 2025 CMD Symposium on the development of NLRP3 inflammasome inhibitors (pictured left).
Matthew hands in his thesis
Apr 2025
After a 3 month grind, Matthew hands in his thesis. We hold our breath for his upcoming viva. Godspeed Matthew.
Teddy hall relays title retained
Mar 2025
The CMD Drug Runners A crushed the competition at the 2025 Teddy Hall Relays averaging 3:44 min/km over the 28 km, winning the departmental category by over 20 minutes, and retaining the title from 2024. This victory cements our status as the fastest research group in Oxford.
Welcome Samuel
Feb 2025
We welcome our newest student, Samuel, who joins us from Cambridge to do his DPhil in Clinical Medicine
2020
Adeus Saleta
2nd October 2020
A sad day as we bid farewell to a true legend of the Brennan Group. Saleta returns back to her native Galicia, and we wish her all the best!
Welcome Mia!
17th August 2020
Mia joins the group as part of her SBM CDT rotation. She’ll be working on the synthesis of fragments targeting the GEF GTPases.
Adios Carmen!
25th June 2020
Our resident social secretary and dream colleague, Carmen, heads off to the big smoke to join the ICR. She’ll be missed!
Au revoir Stephane!
13th May 2020
Another Brennan Group legend bows out, leaving an incredible legacy behind. Stephane heads back to Belgium, and we wish him all the best!
Auf wiedersehen Raina!
25th February 2020
Despite only staying a short while, Raina had an immense impact on the group as both a chemist and a colleague. She begins a new job with Merck back in Germany and we wish her all the best!
Ciao Filippo!
25th February 2020
A true legend of the Brennan Group heads on to pastures new. A sad day as we wave arriverderci to Gian-Filippo as he begins a new job at Evotec. The group wouldn’t be where it was without him, and he’ll be sorely missed.
Ewa joins the group (again)
7th October 2019
Ewa is back for more, this time with us for a whole year as she completes her Part II masters project working on peptide-based ligands for USP7.
Tom joins the group
1st July 2019
Tom joins the group as a post-doctoral researcher looking at the synthesis of NLRP3 inflammasome inhibitors.
Mary and Aidan head off to their second rotations
24th May 2019
SBM’ers Mary and Aidan have finished their rotations and head off to pastures less green but new nonetheless, hopefully see you soon!
Mary and Aidan begin their rotations
4th February 2019
SBM’ers Mary and Aidan join the group to begin their first rotations and continue the great relationship between the SBM and the Brennan group.
Tryfon joins the group
10th October 2018
Tryfon joins the group as a post-doctoral researcher looking at the development of deubiquitinase inhibitors.
Yining starts her DPhil
17th September 2018
Yining rejoins the group following her SBM CDT rotation project to start her full DPhil. Welcome back!
Until next time, Ewa!
14th September 2018
Ewa finishes up in the group after a very successful summer spent working on designing small molecules for the treatment of Friedreich’s Ataxia. We’ll miss you!
Miranda hands in
31st August 2018
The second of our final year DPhil student hands in their thesis! Massive congratulations to Miranda and best of luck at your new job with Vertex!
Professor Brennan is born
31st July 2018
Congratulations to the boss who was made full Professor! Not a bad birthday present.
Moses passes his viva!
29th June 2018
Huge congrats to Moses (aka Dr Moustakim) who passed his viva today!
Ewa joins the group
18th June 2018
Ewa joins the group as a summer intern to work on the development of small molecule inhibitors of SUV420 as a treatment for Friedreich's Ataxia.